199 related articles for article (PubMed ID: 22745586)
1. Epidermal growth factor cytoplasmic domain affects ErbB protein degradation by the lysosomal and ubiquitin-proteasome pathway in human cancer cells.
Glogowska A; Stetefeld J; Weber E; Ghavami S; Hoang-Vu C; Klonisch T
Neoplasia; 2012 May; 14(5):396-409. PubMed ID: 22745586
[TBL] [Abstract][Full Text] [Related]
2. HECT E3 ubiquitin ligase Nedd4-1 ubiquitinates ACK and regulates epidermal growth factor (EGF)-induced degradation of EGF receptor and ACK.
Lin Q; Wang J; Childress C; Sudol M; Carey DJ; Yang W
Mol Cell Biol; 2010 Mar; 30(6):1541-54. PubMed ID: 20086093
[TBL] [Abstract][Full Text] [Related]
3. Ligand-induced lysosomal epidermal growth factor receptor (EGFR) degradation is preceded by proteasome-dependent EGFR de-ubiquitination.
Alwan HA; van Zoelen EJ; van Leeuwen JE
J Biol Chem; 2003 Sep; 278(37):35781-90. PubMed ID: 12829707
[TBL] [Abstract][Full Text] [Related]
4. Ubiquitin C-Terminal Hydrolase L1 is required for regulated protein degradation through the ubiquitin proteasome system in kidney.
Radón V; Czesla M; Reichelt J; Fehlert J; Hammel A; Rosendahl A; Knop JH; Wiech T; Wenzel UO; Sachs M; Reinicke AT; Stahl RAK; Meyer-Schwesinger C
Kidney Int; 2018 Jan; 93(1):110-127. PubMed ID: 28754552
[TBL] [Abstract][Full Text] [Related]
5. The E3 ubiquitin ligase NEDD4 mediates cell migration signaling of EGFR in lung cancer cells.
Shao G; Wang R; Sun A; Wei J; Peng K; Dai Q; Yang W; Lin Q
Mol Cancer; 2018 Feb; 17(1):24. PubMed ID: 29455656
[TBL] [Abstract][Full Text] [Related]
6. Nedd4 mediates ErbB4 JM-a/CYT-1 ICD ubiquitination and degradation in MDCK II cells.
Zeng F; Xu J; Harris RC
FASEB J; 2009 Jun; 23(6):1935-45. PubMed ID: 19193720
[TBL] [Abstract][Full Text] [Related]
7. Investigation of the role of β-TrCP in growth hormone transduction defect (GHTD).
Kostopoulou E; Rojas Gil AP; Spiliotis BE
Horm Mol Biol Clin Investig; 2020 Mar; 41(2):. PubMed ID: 32114520
[TBL] [Abstract][Full Text] [Related]
8. Ubiquitin C-terminal hydrolase-L1 potentiates cancer chemosensitivity by stabilizing NOXA.
Brinkmann K; Zigrino P; Witt A; Schell M; Ackermann L; Broxtermann P; Schüll S; Andree M; Coutelle O; Yazdanpanah B; Seeger JM; Klubertz D; Drebber U; Hacker UT; Krönke M; Mauch C; Hoppe T; Kashkar H
Cell Rep; 2013 Mar; 3(3):881-91. PubMed ID: 23499448
[TBL] [Abstract][Full Text] [Related]
9. Altered gene expression in cells from patients with lysosomal storage disorders suggests impairment of the ubiquitin pathway.
Bifsha P; Landry K; Ashmarina L; Durand S; Seyrantepe V; Trudel S; Quiniou C; Chemtob S; Xu Y; Gravel RA; Sladek R; Pshezhetsky AV
Cell Death Differ; 2007 Mar; 14(3):511-23. PubMed ID: 16888648
[TBL] [Abstract][Full Text] [Related]
10. UCH-L1 induces podocyte hypertrophy in membranous nephropathy by protein accumulation.
Lohmann F; Sachs M; Meyer TN; Sievert H; Lindenmeyer MT; Wiech T; Cohen CD; Balabanov S; Stahl RA; Meyer-Schwesinger C
Biochim Biophys Acta; 2014 Jul; 1842(7):945-58. PubMed ID: 24583340
[TBL] [Abstract][Full Text] [Related]
11. The catalytic region and PEST domain of PTPN18 distinctly regulate the HER2 phosphorylation and ubiquitination barcodes.
Wang HM; Xu YF; Ning SL; Yang DX; Li Y; Du YJ; Yang F; Zhang Y; Liang N; Yao W; Zhang LL; Gu LC; Gao CJ; Pang Q; Chen YX; Xiao KH; Ma R; Yu X; Sun JP
Cell Res; 2014 Sep; 24(9):1067-90. PubMed ID: 25081058
[TBL] [Abstract][Full Text] [Related]
12. USP25 Regulates EGFR Fate by Modulating EGF-Induced Ubiquitylation Dynamics.
Niño CA; Wollscheid N; Giangreco G; Maspero E; Polo S
Biomolecules; 2020 Nov; 10(11):. PubMed ID: 33202887
[TBL] [Abstract][Full Text] [Related]
13. Ubiquitin C-terminal hydrolase-l1 activity induces polyubiquitin accumulation in podocytes and increases proteinuria in rat membranous nephropathy.
Meyer-Schwesinger C; Meyer TN; Sievert H; Hoxha E; Sachs M; Klupp EM; Münster S; Balabanov S; Carrier L; Helmchen U; Thaiss F; Stahl RA
Am J Pathol; 2011 May; 178(5):2044-57. PubMed ID: 21514420
[TBL] [Abstract][Full Text] [Related]
14. Over-expression of ubiquitin carboxy terminal hydrolase-L1 induces apoptosis in breast cancer cells.
Wang WJ; Li QQ; Xu JD; Cao XX; Li HX; Tang F; Chen Q; Yang JM; Xu ZD; Liu XP
Int J Oncol; 2008 Nov; 33(5):1037-45. PubMed ID: 18949367
[TBL] [Abstract][Full Text] [Related]
15. Negative constraints underlie the ErbB specificity of epidermal growth factor-like ligands.
van der Woning SP; van Rotterdam W; Nabuurs SB; Venselaar H; Jacobs-Oomen S; Wingens M; Vriend G; Stortelers C; van Zoelen EJ
J Biol Chem; 2006 Dec; 281(52):40033-40. PubMed ID: 17032651
[TBL] [Abstract][Full Text] [Related]
16. Sulindac metabolites induce proteosomal and lysosomal degradation of the epidermal growth factor receptor.
Pangburn HA; Ahnen DJ; Rice PL
Cancer Prev Res (Phila); 2010 Apr; 3(4):560-72. PubMed ID: 20332299
[TBL] [Abstract][Full Text] [Related]
17. Diacylglycerol kinase delta and protein kinase C(alpha) modulate epidermal growth factor receptor abundance and degradation through ubiquitin-specific protease 8.
Cai J; Crotty TM; Reichert E; Carraway KL; Stafforini DM; Topham MK
J Biol Chem; 2010 Mar; 285(10):6952-9. PubMed ID: 20064931
[TBL] [Abstract][Full Text] [Related]
18. Measuring the Overall Rate of Protein Breakdown in Cells and the Contributions of the Ubiquitin-Proteasome and Autophagy-Lysosomal Pathways.
Sha Z; Zhao J; Goldberg AL
Methods Mol Biol; 2018; 1844():261-276. PubMed ID: 30242715
[TBL] [Abstract][Full Text] [Related]
19. Recycling of EGFR and ErbB2 is associated with impaired Hrs tyrosine phosphorylation and decreased deubiquitination by AMSH.
Meijer IM; van Rotterdam W; van Zoelen EJ; van Leeuwen JE
Cell Signal; 2012 Nov; 24(11):1981-8. PubMed ID: 22800866
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of Usp14 and Uch-L1 on the ubiquitin proteasome system and synaptic activity.
Walters BJ; Campbell SL; Chen PC; Taylor AP; Schroeder DG; Dobrunz LE; Artavanis-Tsakonas K; Ploegh HL; Wilson JA; Cox GA; Wilson SM
Mol Cell Neurosci; 2008 Dec; 39(4):539-48. PubMed ID: 18771733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
